3.5 Medication Administration Support
Key Takeaways
- The CCMA supports medication administration only when trained, delegated, ordered, and permitted by state law and policy.
- NHA scope includes nonparenteral routes and parenteral routes excluding intravenous (no IV push or IV infusion).
- Verify the rights every time: right patient, drug, dose, route, time, plus documentation, reason, response, and refusal.
- Intramuscular sites include deltoid, vastus lateralis, and ventrogluteal; subcutaneous injections go at about a 45-degree angle.
- Document immediately after administration, never before; record drug, dose, route, site, lot, and the patient's response.
Scope: What a CCMA May Do
Medication support is the most law-dependent topic in the chapter. A CCMA may prepare, administer, document, and observe medications only when trained, delegated by a supervising provider, ordered, and permitted by the state and facility. NHA task language specifically includes nonparenteral routes (oral, topical, inhaled, ophthalmic, otic, nasal, rectal) and parenteral routes excluding intravenous — meaning intramuscular (IM), subcutaneous (subcut), and intradermal (ID) injections may be in scope, but IV push and IV infusion are not. The CCMA never independently changes a dose or decides treatment.
The Medication Rights
Verify the rights on every administration, checking the order against the label and the patient three times (when retrieving, when preparing, before giving).
| Right | What to confirm |
|---|---|
| Patient | Two identifiers match the order |
| Drug | Label matches the order; check allergies |
| Dose | Correct amount and concentration |
| Route | Order route matches what you will use |
| Time | Correct timing and frequency |
| Documentation | Chart only after giving |
| Reason | Indication is appropriate |
| Response | Monitor effect and adverse reactions |
| Refusal | Honor and document a refusal |
Injection Routes, Sites, and Angles
| Route | Angle | Common sites | Typical use |
|---|---|---|---|
| Intradermal (ID) | 5-15 degrees | Inner forearm | TB (PPD) test, allergy testing |
| Subcutaneous (subcut) | 45 degrees (90 if pinched) | Upper arm, abdomen, thigh | Insulin, some vaccines |
| Intramuscular (IM) | 90 degrees | Deltoid, vastus lateralis, ventrogluteal | Most vaccines, antibiotics |
The vastus lateralis is the preferred IM site for infants. The deltoid holds smaller adult IM volumes (typically up to ~1 mL). After any injection, apply gentle pressure (do not massage an insulin or anticoagulant site), observe the patient, and dispose of the sharp immediately in the sharps container without recapping.
Storage and Safety
Medication safety extends beyond the injection. Check expiration dates, store refrigerated drugs and vaccines within their temperature range and log temperatures, secure controlled substances, and never use a multidose vial past its beyond-use date. A drug that is expired, mislabeled, or stored improperly is not given — it is reported.
Documentation and Escalation
Document immediately after administration, never before. Charting a medication as given before it is actually administered is a serious documentation error and a frequent NHA distractor. Record the drug, dose, route, site, lot number (for vaccines), time, and the patient's response.
Escalate, do not improvise, when you encounter:
- An unclear, illegible, or incomplete order — clarify with the provider before acting.
- An allergy conflict between the order and the chart.
- A patient refusal — honor it and document.
- An adverse reaction — hives, swelling, difficulty breathing, or fainting after an injection may signal anaphylaxis; activate the emergency response and notify the provider.
Common trap: acting from memory or assumption instead of comparing the provider order, the medication label, and the patient's allergy history. The strong answer verifies the rights and clarifies anything unclear before giving anything.
Needle Selection and Injection Technique
The exam expects basic needle logic. Intramuscular injections use a longer needle (typically 1 to 1.5 inches) at 90 degrees to reach muscle; subcutaneous injections use a short needle (about 5/8 inch) at 45 degrees into fatty tissue; intradermal uses a very fine, short needle at a shallow 5-to-15-degree angle to raise a wheel just under the skin. Viscous or oil-based medications need a larger-bore (lower gauge) needle. Before an IM or subcut injection, clean the site with an antiseptic swab in a circular outward motion and let it dry.
After withdrawing the needle, engage the safety device immediately and drop the sharp into the sharps container without recapping — recapping is a leading cause of needlestick injury and is a recurring NHA wrong answer.
Reading the Order and Calculating Safely
A CCMA does not change doses, but does need to read an order correctly and recognize when a calculation looks wrong. Match the ordered dose to the medication concentration on the label. For example, if the order is 250 mg and the vial is labeled 500 mg per 1 mL, the volume is 250 / 500 = 0.5 mL. If a calculation produces an implausible volume — say several milliliters for a single IM injection, which often exceeds a safe single-site volume — that is a signal to stop and verify with the provider rather than proceed.
Always double-check high-alert medications such as insulin and anticoagulants, and never assume a leftover or unlabeled syringe contains what you think it does.
Worked Medication Scenario
The provider orders an IM antibiotic. You retrieve the vial and notice the label name matches, but the patient's chart lists an allergy to that drug class with a reaction of 'hives and throat swelling.' The correct sequence: stop, do not draw up or give the medication, and notify the provider of the documented allergy conflict before anything else. If the patient instead refuses an injection they are due, you honor the refusal, explain you will inform the provider, and document the refusal — you never give a medication a competent patient declines.
After any injection that is given, you watch for adverse reactions, keep epinephrine and the emergency plan accessible in case of anaphylaxis, and document the drug, dose, route, site, lot number, time, and patient response immediately afterward.
At what angle is a subcutaneous injection typically given when the skin is not pinched?
A CCMA has prepared an injection but the provider's order is illegible regarding the dose. What is the safest action?
Which medication task falls OUTSIDE the typical CCMA scope under NHA task statements?